{"name":"iCAD","slug":"icad","ticker":"ICAD","exchange":"NASDAQ","domain":"icadmed.com","description":"iCAD is a medical technology company specializing in artificial intelligence (AI) diagnostics. The company focuses on developing and commercializing AI-powered computer-aided detection (CAD) solutions for various medical imaging modalities. iCAD's products are designed to improve the accuracy and efficiency of cancer detection and diagnosis. The company's products are used in the US and internationally, with a strong presence in the radiology market.","hq":"Nashua, NH","founded":0,"employees":"","ceo":"Dana Brown","sector":"Medical Technology / AI Diagnostics","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$105M","metrics":{"revenue":31340000,"revenueGrowth":22.3,"grossMargin":0,"rdSpend":6609000,"netIncome":-5616000,"cash":37540000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-27","type":"earnings","headline":"iCAD Reports Fourth Quarter and Full Year 2022 Financial Results","summary":"iCAD reported its financial results for Q4 and FY 2022, with revenue of $14.1 million and a net loss of $6.2 million.","drugName":"","sentiment":"neutral"},{"date":"2022-09-22","type":"deal","headline":"iCAD Announces Collaboration with Philips to Develop AI-Powered Breast Cancer Detection Solution","summary":"iCAD partnered with Philips to develop an AI-powered breast cancer detection solution for mammography.","drugName":"","sentiment":"positive"},{"date":"2022-06-29","type":"regulatory","headline":"iCAD Receives FDA Clearance for Xoft Axxent eBx Electronic Brachytherapy System","summary":"iCAD received FDA clearance for its Xoft Axxent eBx electronic brachytherapy system, a non-invasive cancer treatment.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPUTdGSWhCSHM5X0lkeWk3cTAzQU13bEEtU3pFWWpEZDZZQ0xEWlR1dTlaVHhXNTcwQjREY3N1bnczVFQ3bnNhSXF2aDVtVWxEeG5iREt5MGR4SERDaEg1b1JkRWJYOWFKZ0huNEJ1MlJLWGpwZmJEelJfSjdxR0dOLWdXOW5sY0xTU1QybWplNUo0WFJjeUx6M1RWQzZlbnRkMnQtU1lyWWloaHhRUlZYMTNXUE1XeHYwemItcQ?oc=5","date":"2025-11-16","type":"pipeline","source":"ZAWYA","summary":"TAQA launches major building retrofit project at ICAD Residential City - ZAWYA","headline":"TAQA launches major building retrofit project at ICAD Residential City","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQZEc2VDJ5aFpGeEQ2WmFlOC15LWJ2N0VaY19Tek5WNjZWR2hWMzJkS1V0ZnliUnBNY1VEMS1ZbmlBZG1IT3h4MlVFelh4aG5JNzVhNWEzd0taQkdJU0FERUUxZThrTnVKd1ZEWkdxS1Y5UW1MU0VRZ0kwWjdLaUhIMWlmaldZcGkxQnlUcUo3X2xMZW15bzYxTmZkS096QQ?oc=5","date":"2025-08-12","type":"deal","source":"bioworld.com","summary":"Deephealth closes $110M Icad buy, gains Techlive clearance - bioworld.com","headline":"Deephealth closes $110M Icad buy, gains Techlive clearance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNVmZERFFQdEp2ZXhCRXQySlN3clF2bjl2UEhWeXNPaE50cTJmcVA5WHZ4YVBjRThNdEhIR29MUEpUbUstWXpWMHUwMk5zeGpRSnFLbExuVUlhZTE0dU9PQTJaTGlqcmladWkwNHc3TE1rbzlBTUpHdkQ4TThtc3FSTmd0X20?oc=5","date":"2025-07-21","type":"pipeline","source":"Medical Device Network","summary":"RadNet’s DeepHealth concludes iCAD acquisition - Medical Device Network","headline":"RadNet’s DeepHealth concludes iCAD acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOZkdCTmVYZ0xETlJvS3d2QU80RERfYlBYQ3ZoU3FyUm1LdWg1SjZPQkZFdlRxQ05DLUdKdUpBN3lXQUt1MU5jbnZNbE1QdlA0YXRvRkpmWmxLR3VtX2ltUGh5MGhTc1BEYTVDRUVFS3BkamQwNEV0WDJUU3NQakRaQlNCeHNsNHd3YzRqUEFSVTBxeDd6XzBET1kxRmQ3RlU0NUw2VQ?oc=5","date":"2025-07-18","type":"pipeline","source":"MassDevice","summary":"RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio - MassDevice","headline":"RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPV3k1YkxYLVZ1bzNZZGozWDRlU3NzVlliWjlKUDNOTnpGZmZYV09fZDRjWFhRZVJfWnBaaGEya2gtcXdoQzNTaUwybkl0WWd2ZmhMMnNnTW0tb0xJcHZvcjZYTzVEV2dCb3hyVGFWbGlrTDRsWHFGNkFlOUtnMUc1R2FPdTVaMGtIZ0FvY3BLMk5VcVo0Y0xqcGFWM05ZZktqczZj?oc=5","date":"2025-04-21","type":"deal","source":"Perkins Coie","summary":"Perkins Coie Advises RadNet, Inc. in Agreement to Acquire iCAD, Inc. - Perkins Coie","headline":"Perkins Coie Advises RadNet, Inc. in Agreement to Acquire iCAD, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQZThhT3o2YnlLNC1rSy1sWmJFN2hYZjkzdzRkTjl3N1Z3QmRadEhyTU92LXoxQ0l1UndIR2FnVDdOQmZkVDYtWmVWOFFWWll5SzNEbUE0OXhTTlJLLWxhTTJQcUtMbVBXQkZUSE9HR3Q0UmpoNW5zREpxMS1WNHlwM3RScjdRWldWOHVDZGpWdFlMZ0F0dFEzMlQwUndNUXFQY1E?oc=5","date":"2025-04-17","type":"pipeline","source":"statnews.com","summary":"To speed adoption of breast cancer AI, a radiology network plots an acquisition - statnews.com","headline":"To speed adoption of breast cancer AI, a radiology network plots an acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOZ1BTUER0SXJyZkRTRDFwX01QM2ZSeGJmNFlaS0x3bzk0RWpCdm9BNjc2U3NiUWVraGZvSFRValZBd293bkU4VDU5N3lZS3pFYTVQemVqM2tQLWlMTXhzWU1HcHNRdTZKekVYYzJyT29LZURQODVTUkc5OGpFaktpMHMzdENnOVR5LUU2NExvVjBBU3d1OUE?oc=5","date":"2025-04-16","type":"deal","source":"Fierce Biotech","summary":"RadNet to absorb mammography AI developer iCad in $103M deal - Fierce Biotech","headline":"RadNet to absorb mammography AI developer iCad in $103M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPZHhHXzk5QjY0THg4RzBqNkRTeEs5amcyZHI2MFp4Q2ZJRG9xRFZvSmZwWENLbTFuNWJXRXludTRrZ3poZGIyckNtazU4Sk5aNTlVQXhmdnhrdFdodWVvN1JZa2hRM08zRVF6UUc5dktVN0hfbTZDQkVWZC1Ed3dENjROZW5wWjQ0YjFJSTBwZEJETGNmeko5ZlRUX2hGdmdreUpYVUxtVTh6TUZybVprN3dfMjBtaTVrS056OXg5WWJjS0lrS0xwWWV1emtyRWtJVW53dmJVX09feGpDN0tkY1Y2NWZRQzlzandJZDBGSWFwV0U3eVQ2V2FWUTE?oc=5","date":"2025-04-08","type":"pipeline","source":"globenewswire.com","summary":"iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer - globenewswire.com","headline":"iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQY2ZjemxaNEhrWS01OTRwdFA3OHZ5Z2xUZjFoVV9WZjJmMEJmN1RBUjdTU1drTmVlMEFwU0RWOHQ1RHkzd0c1STM1LUxlZDZIZzIxcW4zQ3JaRUNacWpabGh5TkVDM1VYS01YRXV2bFNUZmZiWW1lVTN6Qk43ZjhhdktLS2lTMm5ZaDlGYmNJX0xtSzJpa2M1YURobGJaRDVXWVVsakQ1My03TXdaNzZ0MVozckxtcHVud0Qzdk5CdVZHUmt0Y1hN?oc=5","date":"2023-11-28","type":"pipeline","source":"dicardiology.com","summary":"iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease - dicardiology.com","headline":"iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9POFctSk84bjFXSTdudTJoNklHTDlTSS11RVVUNzBHZ1JXM3dZalIzNV9LZjVlRTM5N1BlRHIzSXhTbXF2NW1mVERRY1FZTU5wR1VEVksybUY0djFLRWZpdjF6enlaVEVFc3htMFBTZXg4LUJCblFN?oc=5","date":"2023-04-17","type":"pipeline","source":"MedTech Dive","summary":"iCAD, in midst of restructuring, names three new top executives - MedTech Dive","headline":"iCAD, in midst of restructuring, names three new top executives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQcHBJYjRuY2RDWGhaTXZzTGNkVEFhMmRvdFFjYjNGbHdRSWtaaU9MYkpzbWtnYml5Slg2NUFfSXdURDl5anFCaWZfWjFfcG1jRVBPUkp3enlYUzNqWUZyMVU3MnVod0lJVjYzREFlN3hWR0hkdUlGc3hfVHFjS0RhQWNmdEZ1N3o3a2FzdzRLb1otaFE4?oc=5","date":"2022-11-28","type":"deal","source":"MobiHealthNews","summary":"Google Health licenses breast cancer screening AI to iCAD - MobiHealthNews","headline":"Google Health licenses breast cancer screening AI to iCAD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQUzdxcHJnbUhkRHBlVzdxaWUycXhkdTVCemV2QWdtZklXdmFscm1LMXh5NVhoZk5mZUN1Q3gzTWdtbl95bHRQWG5CS0tLSkx6ZFNHQ1luU0MtWGxwSXR3M1VSdDlqWWczRzBVVHpsXzZZR215S1QyNnVGMmhLb1VhUUxvVlR0YlZOTDJyOVkyaDRUc01JQm8tUHBBUVBRRjk2RUhCeGZIZkZmcl96UzZHanZsN29URUNzRlo2cFByS3B4SWlH?oc=5","date":"2022-11-28","type":"deal","source":"Medical Design & Outsourcing","summary":"How Google and iCAD will partner to advance AI mammography - Medical Design & Outsourcing","headline":"How Google and iCAD will partner to advance AI mammography - Medical Design & Outsourcing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Hologic","Philips","Siemens Healthineers"],"therapeuticFocus":["Cancer Detection and Diagnosis","Radiology"],"financials":{"source":"sec_edgar+yahoo","revenue":31340000,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":31340000,"period":"2019-12-31"},{"value":25621000,"period":"2018-12-31"},{"value":25621000,"period":"2018-12-31"},{"value":25621000,"period":"2018-12-31"},{"value":28102000,"period":"2017-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":6609000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5616000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":37540000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}